We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Breathalyzer Monitors Blood Glucose in Diabetics

By LabMedica International staff writers
Posted on 26 Nov 2013
A novel noninvasive breathalyzer device has been created that can monitor blood glucose levels in diabetics by detecting acetone levels. More...


Current technology to measure blood glucose includes the use of a portable testing meter that can measure sugar levels in the body from a small drop of blood, but it is invasive, can often cause discomfort for the patient, and can lead to low compliance with poor health consequences.

Scientists at the Western New England University (Springfield, MA, USA) produced a hand-held breathalyzer that uses nanometer-thick films that are made up of two polymers. These polymers are able to react with acetone. Acetone is one of the ketones, which are acids that remain in the body when the body burns its own fat. Ketones build up when there is not enough insulin to help fuel the body's cells, meaning they are more common in people with diabetes.

In the breathalyzer device, the acetone adheres to the polymers and alters the physical chemistry of the film. The film then discloses the amount of acetone detected, which in turn reveals glucose levels in the blood. At present, the breathalyzer is similar in size to a book; however, an engineer at Western New England University is helping to make the device similar in size to breathalyzers that are used to detect blood alcohol content levels.

Ronny Priefer, PhD, the designer of the device said, “Breathalyzers are a growing field of study because of their potential to have a significant positive impact on patients' quality of life and compliance with diabetes monitoring. What makes our technology different is that it only accounts for acetone and doesn't react with other components in the breath.”

Prof. Preifer added that common shortfalls with other breathalyzer technologies have included inconsistent results due to natural humidity in the breath, high temperature requirements, and lack of differentiation. The study was presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition held November 10-14, 2013, in San Antonio (TX, USA).

Related Links:

Western New England University




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.